Iason GmbH has continued its refinancing efforts with local banks based on an IBR
The shareholders of Iason GmbH have completed a restructuring of the company and its refinancing efforts with local banks based on an IBR.
The Iason group produces radiopharmaceuticals and supplies special laboratory products to the target group "nuclear medicine" and "laboratory medicine" providing innovative products with the highest quality standards. The company has customers from all over Europe.
Oaklins' team in Austria assisted Iason with the preparation of the IBR (independent business review) and negotiations with local banks regarding refinancing possibilities.
Sprechen Sie mit dem Deal-Team
Geschäftsführender PartnerWien, Österreich
BlijWerkt has been acquired by Mentha Capital
Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.Weitere Informationen
Medical Mutual of Ohio has acquired Bravo Wellness, LLC
Medical Mutual of Ohio on the acquisition of Bravo Wellness, LLC.Weitere Informationen
Lead Healthcare has successfully raised financing provided by Rabobank
Lead Healthcare has successfully raised financing provided by Rabobank.Weitere Informationen